Figure 11. Disposition of Submission by Medela, Inc. (Text description

Technology assessment on negative pressure wound therapy devices.


Select [D] below for full text description of this figure.

Figure 11 is an attrition diagram that depicts the status of documents that Medela Inc. submitted for possible inclusion in the report.

The diagram begins with a box outlining the total submission of 10 documents. Several boxes ensue which are connected by arrows going from top to bottom which follow the submissions as they are being screened for possible inclusion in the report.

In the first frame, we compare Medela's submission to submissions by other interested stakeholders and remove any duplicates. Medela had zero duplicate submissions.

An arrow leads from the 10 Unique Submissions to the Initial Screening Phase where documents may be excluded, used in our Background Section or passed to the next level. In this instance, 1 document was identified for exclusion due to "personal communication".

Zero documents were identified for inclusion in our Background Section.

The path then follows the 9 full articles remaining. During this phase of screening we do a more extensive screening which is again based on our pre-determined inclusion/exclusion criteria. Go to our Methods Section for additional information on the criteria.

9 full articles were excluded during this evaluation phase; 2 were animal studies; 2 were narrative reviews; and 5 were excluded for Other Reasons which may include "inclusion of healthy subjects", "lack of reporting wound healing outcomes" or "patients treated with dual therapies."

Due to the exclusion of all 9 submissions at this level, zero submissions remained for possible inclusion in the report. Note: Language has been corrected to reflect screening of meeting abstracts, poster presentations and other documents in addition to abstracts of full articles.

Return to Document

Current as of November 2009
Internet Citation: Figure 11. Disposition of Submission by Medela, Inc. (Text description. November 2009. Agency for Healthcare Research and Quality, Rockville, MD.